Soluble interferon-γ receptors encoded by poxviruses

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 19, Issue 4, 1996, Pages 305-317

  Alcamí, Antonio ^a   Smith, Geoffrey L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytokine receptor; Immune evasion; Interferon; Pathogenesis; Poxvirus; Vaccinia; Virus evolution

Indexed keywords

GAMMA INTERFERON; INTERFERON RECEPTOR;

ARTICLE; HUMAN; LEPORIPOXVIRUS; PATHOGENESIS; POXVIRUS; POXVIRUS INFECTION; SMALLPOX; SPECIES DIFFERENCE; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

LEPORIPOXVIRUS; MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS; POXVIRIDAE; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 0030249374     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0147-9571(96)00013-6     Document Type: Article

References (72)

1. 1. Fenner F. Poxviruses. In Virology. Fields B. N., Knipe D. M., Chanock R. M., Hirsch M. S., Melnick J., Monath T. P. and Roizman B. (Eds), pp. 2113-2133. Raven Press, New York (1990).
2. 2. Moss B. Poxviridae and their replication. In Virology. Fields B. N., Knipe D. M., Chanock R. M., Hirsch M. S., Melnick J., Monat T. P. and Roizman B. (Eds), pp. 2079-2111. Raven Press, New York (1990).
3. 3. Fenner F., Anderson D. A., Arita I., Jezek Z. and Ladnyi I. D. Smallpox and Its Eradication. World Health Organisation, Geneva (1988).
4. 4. Baxby D. Jenner's Smallpox Vaccine. The Riddle of the Origin of Vaccinia Virus. Heinemann, London (1981).
5. 5. Fenner F., Wittek R. and Dumbell K. R. The Orthopoxviruses. Academic Press, Inc., London (1989).
6. 6. Downie A. W. A study of the lesions produced experimentally by cowpox virus. J. Pathol. Bacterial. 48, 361-379 (1939).
7. 7. Mackett M. and Archard L. C. Conservation and variation in Orthopoxvirus genome structure. J. Gen. Virol 45, 683-701 (1979).
8. 8. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P. and Paoletti E. The complete DNA sequence of vaccinia virus. Virology 179, 247-266 (1990).
9. 9. Aguado B., Selmes I. P. and Smith G. L. Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. J. Gen. Virol. 73, 2887-2902 (1992).
10. 10. Massung R. F., Esposito J. J., Liu L., Qi J., Utterback T. R., Knight J. C., Aubin L., Yuran T. E., Parsons J. M., Loparev V. N., Selivanov N. A., Cavallaro K. F., Kerlavage A. R., Mahy B. W. J. and Venter J. C. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366, 748-751 (1993).
11. 11. Shchelkunov S. N., Blinov V. M., Resenchuk S. M., Totmenin A. V. and Sandakhchiev L. S. Analysis of the nucleotide sequence of a 43 kbp segment of the genome of variola virus India-1967 strain. Virus Res. 30, 239-258 (1993).
12. 12. Shchelkunov S. N., Blinov V. M., Totmenin A. V., Marennikova S. S., Kolykhalov A. A., Frolov I. V., Chizhikov V. E., Gytorov V. V., Gashikov P. V., Belanov E. F., Belavin P. A., Resenchuk S. M., Andzhaparidze O. G. and Sandakhchiev L. S. Nucleotide sequence analysis of variola virus HindIII M, L, I genome fragments. Virus Res. 27, 25-35 (1993).
13. 13. Massung R. F., Liu L., Qi J., Knight J. C., Yuran T. E., Kerlavage A. R., Parsons J. M., Venter J. C. and Esposito J. J. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201, 215-240 (1994).
14. 14. Shchelkunov S. N., Blinov V. M., Resenchuk S. M., Totmenin A. V., Olenina L. V., Chirikova G. B. and Sandakhchiev L. S. Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola virus strain India-1967. Virus Res. 34, 207-236 (1994).
15. 15. Shchelkunov S. N., Resenchuk S. M., Totmenin A. V., Blinov V. M. and Sandakhchiev L. S. Analysis of the nucleotide sequence of 48 kbp of the variola major virus strain India-1967 located on the right terminus of the conserved genome region. Virus Res. 32, 37-55 (1994).
16. 16. Fenner F. and Ratcliffe F. N. Myxomatosis. Cambridge University Press, London (1965).
17. 17. Buller R. M. L. and Palumbo G. J. Poxvirus pathogenesis. Microbiol. Rev. 55, 80-122 (1991).
18. 18. Smith G. L. Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74, 1725-1740 (1993).
19. 19. McFadden G. and Graham K. Modulation of cytokine networks by poxvirus: the myxoma virus model. Sem. Virology 5, 421-429 (1994).
20. 20. Smith G. L. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2, 81-88 (1994).
21. 21. Spriggs M. K. Cytokine and cytokine receptor genes "captured" by viruses. Curr. Opin. Immunol. 6, 526-529 (1994).
22. 22. Alcamí A. and Smith G. L. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today 16, 474-478 (1995).
23. 23. McFadden G. Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. R. G. Landes Company, Georgetown, Texas (1995).
24. 24. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R.t Salvesen G. S. and Pickup D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69, 697-604 (1992).
25. 25. Akkaraju G. R., Whitaker-Dowling P., Youngner J. S. and Jagus R. Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. J. biol. Chem. 264, 10321-10325 (1989).
26. 26. Watson J. C., Chang H. W. and Jacobs B. L. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology 185, 206-216 (1991).
27. 27. Chang H. W., Watson J. C. and Jacobs B. L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl Acad. Sci. USA 89, 4825-4829 (1992).
28. - mutant viruses. Virology 210, 254-263 (1995).
29. 29. Beattie E., Tartaglia J. and Paoletti E. Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 183, 419-422 (1991).
30. 30. Davies M. V., Elroy-Stein O., Jagus R., Moss B. and Kaufman R. J. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 1945-1950 (1992).
31. 31. Shchelkunov S. N., Blinov V. M. and Sandakhchiev L. S. Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms. FEBS Lett. 319, 80-83 (1993).
32. 32. Upton C., Macen J. L., Schreiber M. and McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370-382 (1991).
33. 33. Smith C. A., Davis T., Wignall J. M., Din W. S., Farrah T., Upton C., McFadden G. and Goodwin R. G. T2 open reading frame from Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. biophys. Res. Commun. 176, 335-342 (1991).
34. 34. Hu F., Smith C. A. and Pickup D. J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204, 343-356 (1994).
35. 35. Alcamí A. and Smith G. L. Comment on the paper by Shchelkunov et al. (1993) FEBS Lett. 319, 80-83. Two genes encoding poxvirus cytokine receptors are disrupted or deleted in variola virus. FEBS Lett. 335, 136-137 (1993).
36. 35. Alcamí A. and Smith G. L. Comment on the paper by Shchelkunov et al. (1993) FEBS Lett. 319, 80-83. Two genes encoding poxvirus cytokine receptors are disrupted or deleted in variola virus. FEBS Lett. 335, 136-137 (1993).
37. 36. Howard S. T., Chan Y. S. and Smith G. L. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumour necrosis factor receptor family. Virology 180, 633-647 (1991).
38. 37. Alcamí A. and Smith G. L. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167 (1992).
39. 38. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M. and VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71, 145-152 (1992).
40. 39. Upton C., Mossman K. and McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258, 1369-1372 (1992).
41. 40. Alcamí A. and Smith G. L. Vaccinia, cowpox and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69, 4633-4639 (1995).
42. 41. Mossman K., Upton C., Buller R. M. L. and McFadden G. Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins. Virology 208, 762-769 (1995).
43. 42. Colamonici O. R., Domanski P., Sweitzer S. M., Larner A. and Buller R. M. L. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon a transmembrane signaling. J. biol. Chem. 270, 15974-15978 (1995).
44. 43. Symons J. A., Alcamí A. and Smith G. L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560 (1995).
45. 44. Massung R. F., Jayarama V. and Moyer R. W. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 197, 511-528 (1993).
46. 45. Cao J. X., Gershon P. D. and Black D. N. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology 209, 207-212 (1995).
47. 46. Pestka S., Langer J. A., Zoon K. C. and Samuel C. E. Interferons and their actions. Ann. Rev. Biochem. 56, 727-777 (1987).
48. 47. Farrar M. A. and Schreiber R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611 (1993).
49. 48. Ealick S. E., Cook W. J., Vijay-Kumar S., Carson M., Nagabhushan T. L., Trotta P. P. and Bugg C. E. Three-dimensional structure of recombinant human interferon-γ. Science 252, 689-702 (1991).
50. 49. Aguet M., Dembic Z. and Merlin G. Molecular cloning and expression of the human interferon-γ receptor. Cell 55, 273-280 (1988).
51. 50. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 87, 6934-6938 (1990).
52. 51. Soh J., Donnely R. O., Kotenko S., Mariano T. M., Cook J. R., Wang N., Emanuel S., Schwartz B., Miki T. and Pestka S. Identification and sequence of an accessory factor required for activation of the human IFN-gamma receptor. Cell 76, 793-802 (1994).
53. 52. Fountoulakis M., Juranville J.-F., Stüber D., Weibel E. K. and Garotta G. Purification and biochemical characterization of a soluble human interferon-γ receptor expressed in Escherichia coli. J. biol. Chem. 265, 13268-13275 (1990).
54. 53. Fountoulakis M., Schlaeger E.-J., Gentz R., Juranvitle J.-F., Manneberg M., Ozmen L. and Garotta G. Purification and biochemical characterization of a soluble mouse interferon-γ receptor produced in insect cells. Eur. J. Biochem. 198, 441-450 (1991).
55. 54. Walter M. R., Windsor W. T., Nagabhushan T. L., Lundell D. J., Lunn C. A., Zauodny P. J. and Narula S. K. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature 276, 230-235 (1995).
56. 55. Novick D., Engelmann H., Wallach D. and Rubinstein M. Soluble cytokine receptors are present in normal urine. J. exp. Med. 170, 1409-1414 (1989).
57. 56. Samuel C. E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183, 1-11 (1991).
58. 57. Czarniecki C. W., Hamilton E. B., Fennie C. W. and Wolf R. L. In vitro biological activities of Escherichia coli-derived bovine interferons-α, -β, and -γ. J. Interferon Res. 6, 29-37 (1986).
59. 58. Dijkema R., van der Meide P. H., Pouwels P. H., Caspers M., Dubbeld M. and Schellekens H. Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J. 4, 761-767 (1985).
60. 59. van der Meide P. H., Dubbeld M., Vijverberg K., Kos T. and Schellekens H. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67, 1059-1071 (1986).
61. 60. Upton C. and McFadden G. Tumorigenic poxviruses: analysis of the viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology 152, 308-321 (1986).
62. 61. Karupiah G., Blanden R. V. and Ramshaw I. A. Interferon-γ is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin-2 infection. J. exp. Med. 172, 1495-1503 (1990).
63. 62. Kohonen-Corish N. R. J., King N. J. C., Woodhams C. E. and Ramshaw I. A. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ. Eur. J. Immunol. 20, 157-161 (1990).
64. 63. Karupiah G., Fredrickson T. N., Holmes K. L., Khairallah L. H. and Buller R. M. L. Importance of interferons in recovery from mousepox. J. Virol. 67, 4214-4226 (1993).
65. 64. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M. and Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745 (1993).
66. 65. Müller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M. and Aguet M. Functional role of type I and type II interferons in antiviral defence. Science 264, 1918-1921 (1994).
67. 66. Karupiah G., Xie Q., Buller R. M. L., Nathan C., Duarte C. and MacMicking J. D. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448 (1993).
68. 67. Melková Z. and Esteban M. Interferon-γ severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line. Virology 198, 731-735 (1994).
69. 68. Harris N., Buller R. M. L. and Karupiah G. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69, 910-915 (1995).
70. 69. Mossman K., Upton C. and McFadden G. The myxoma virus-soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species-specific manner. J. biol. Chem. 270, 3031-3038 (1995).
71. 70. Marennikova S. S., Ladnyi I. D., Ogorodnikova Z. I., Shelukhina E. M. and Maltseva N. N. Identification and study of a poxvirus isolated from wild rodents in Turkmenia. Archs Virol. 56, 7-14 (1978).
72. 71. Katze M. G. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3, 75-78 (1995).